Charles Schwab Investment Management »

Contineum Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $829k 43k 19.14
2024-06-30 $912k 52k 17.61